Results 241 to 250 of about 54,015 (281)

Pronounced expression of extracellular matrix proteoglycans regulated by Wnt pathway underlies the parallel evolution of lip hypertrophy in East African cichlids. [PDF]

Elife
Machii N, Hatashima R, Niwa T, Taguchi H, Kimirei IA, Mrosso HDJ, Aibara M, Nagasawa T, Nikaido M.   +8 more
europepmc   +1 more source

Recent Advances in Enzymes and Chemoenzymatic Synthesis of Tetrasaccharide Linkage Region of Proteoglycans. [PDF]

Chembiochem
Lin PH, Huang X.
europepmc   +1 more source

B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer. [PDF]

J Immunother Cancer
Stucchi S, Borea R, Garcia-Recio S, Zingarelli M, Rädler PD, Camerini E, Marnata Pellegry C, O'Connor S, Earp HS, Carey LA, Perou CM, Savoldo B, Dotti G.   +12 more
europepmc   +1 more source

Chondroitin sulfate proteoglycans in neural development and regeneration

Current Opinion in Neurobiology, 2005
Proteoglycans are of two main types, chondroitin sulfate (CSPGs) and heparin sulfate (HSPGs). The CSPGs act mainly as barrier-forming molecules, whereas the HSPGs stabilise the interactions of receptors and ligands. During development CSPGs pattern cell migration, axon growth pathways and axon terminations.
CARULLI, Daniela, LAABS T, GELLER H. M, FAWCETT J. W.   +3 more
openaire   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma

Methods in molecular biology, 2013
The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a useful biomarker to identify melanoma cells and an attractive target to apply antibody-based immunotherapy for the treatment of melanoma. Here we described the reverse transcription-polymerase chain reaction (RT-PCR) method and the immunohistochemical (IHC) staining method to ...
Wang, Yangyang, Sabbatino, Francesco, Wang, Xinhui, Ferrone, Soldano   +3 more
openaire   +5 more sources

Stimulation of Chondroitin Sulfate Proteoglycan Production by Chondrocytes in Monolayer

Connective Tissue Research, 1975
Chondrocytes in monolayer undergo morphological and biochemical changes which culminate in the establishment of cartilage nodules in vitro. Chondroitin sulfate or heparin, added to the culture media of these cells, stimulates the production of chondroitin sulfate proteoglycan over the entire period of culture with a maximum effect during the log phase ...
Albert Dorfman, Nancy B. Schwartz
openaire   +4 more sources

Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4

Advances in Cancer Research, 2010
The lack of effective conventional therapies for the treatment of advanced stage melanoma has stimulated interest in the development of novel strategies for the management of patients with malignant melanoma. Among them, immunotherapy has attracted much attention because of the potential role played by immunological events in the clinical course of ...
Michael Campoli, Soldano Ferrone, Xinhui Wang   +2 more
openaire   +4 more sources

Neurocan: a brain chondroitin sulfate proteoglycan

Cellular and Molecular Life Sciences, 2001
Neurocan is a chondroitin sulfate proteoglycan of the lectican family and a component of the extracellular matrix of the central nervous system. It is mainly expressed during modeling and remodeling stages of this tissue. Neurocan can bind to various structural extracellular matrix components, such as hyaluronan, heparin, tenascin-C and tenascin-R, and
Xiao-Hong Zhou, Uwe Rauch, K Feng
openaire   +3 more sources

Inhibition of Chondroitin Sulfate Proteoglycans by APRIL

2020
Chondroitin sulfate proteoglycans (CSPGs) are major constituents of the extracellular matrix and well-established obstacles to regeneration in the central nervous system. As such, they are promising targets for therapy in neurological pathologies where repair is needed, such as spinal cord injuries, and multiple sclerosis.
Bertrand Huard, Mashal Claude Ahmed
openaire   +3 more sources